European Archives - Page 127 of 1608 - European Medical Journal

Preoperative Bisphosphonates in Primary Hyperparathyroidism Surgery

Primary hyperparathyroidism (PHPT) is one of the most common endocrine disorders, characterised by excessive parathyroid hormone secretion…

Simultaneous Double Osteotomy for Severe Genu Varum

Severe constitutional genu varum in young adults often leads to abnormal mechanical loading across the knee, accelerating media….

TEAM Model and Bone Health in Orthopaedic and Spine Surgery

The Centers for Medicare & Medicaid Services (CMS) Transforming Episode Accountability Model (TEAM) is a mandatory 5-year, episode-based….

Osteoporosis Canada and Fracture Liaison Service Expansion

Osteoporosis Canada is the only organisation in Canada serving people affected by osteoporosis. The organisation works to empower…

Opportunistic Vertebral Fracture Diagnosis via CT in Portugal

Vertebral fractures are among the most common fragility fractures in patients with osteoporosis, accounting for nearly 50% of all…

Person holding a wax model of ovaries in their palms

NHS rolls out first new ovarian cancer drug in 20 years

The targeted therapy will be available for patients with epithelial ovarian, peritoneal, or fallopian tube cancers.

New Classification Criteria in SpA: EULAR 2026

Classification criteria and recommendations for the diagnosis and clinical management of spondyloarthritis have been updated and were presented at EULAR 2026.

Improving the Patient Experience in Rheumatology: EULAR 2026

Researchers have highlighted, at EULAR 2026, different pathways through which the rheumatology patient’s experience can be enhanced.

New Life-Extending Drug for Women with Ovarian Cancer

A new ovarian cancer drug, mirvetuximab soravtansine, has been approved on the NHS, offering improved survival and better tolerability for patients with treatment-resistant ovarian cancer through a targeted antibody-drug approach.

Early Neonatal Infection Linked to Cerebral Palsy Risk

A cohort study of over one million children has found that neonatal infection significantly increases risk of cerebral palsy, especially severe motor subtypes and nonambulatory outcomes.